Evidence map›Paper›PMID 37139123›Full record

ArticleFrontiers in cardiovascular medicine2023

Case report: mRNA-1273 COVID-19 vaccine-associated myopericarditis: Successful treatment and re-exposure with colchicine.

Luca Valore, Till Junker, Eva Heilmann, Christine S Zuern, Matthias Streif, Beatrice Drexler, Christian Arranto, Jörg P Halter, Christoph T Berger

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Luca ValoreHematology, University Hospital Basel, Basel, Switzerland.
Till JunkerHematology, University Hospital Basel, Basel, Switzerland.
Eva HeilmannHematology, Cantonal Hospital Aarau, Aarau, Switzerland.
Christine S ZuernCardiology, University Hospital Basel, Basel, Switzerland.
Matthias StreifRadiology, University Hospital Basel, Basel, Switzerland.
Beatrice DrexlerHematology, University Hospital Basel, Basel, Switzerland.
Christian ArrantoHematology, University Hospital Basel, Basel, Switzerland.
Jörg P HalterHematology, University Hospital Basel, Basel, Switzerland.
Christoph T BergerTranslational Immunology, University Basel, Basel, Switzerland.
University Hospital of Basel · CHUniversity of Basel · CHKantonsspital Aarau · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Vaccine-induced myocarditis is a rare complication of messenger RNA (mRNA) COVID-19 vaccines. Case presentation: We report a case of acute myopericarditis in a recipient of allogeneic hematopoietic cells following the first dose of the mRNA-1273 vaccine and the successful administration of a second and third dose while on prophylactic treatment with colchicine to successfully complete the vaccination. Conclusion: Treatment and prevention of mRNA-vaccine-induced myopericarditis represent a clinical challenge. The use of colchicine is feasible and safe to potentially reduce the risk of this rare but severe complication and allows re-exposure to an mRNA vaccine.

Indexed as

allogeneic stem cells transplantationcolchicineCOVID-19mRNA-1273mRNA vaccinemyocarditis

Identifiers

PMID37139123
PMCPMC10149711
OpenAlexW4366218967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.